XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://xconomy.com/europe/2020/06/30/mereo-biopharma-appoints-john-lewicki-chief-scientific-officer/60%Monthly2020-06-30 16:59
https://xconomy.com/boston/2020/06/30/akcea-therapeutics-names-tracy-palmer-berns-chief-compliance-officer/60%Monthly2020-06-30 17:27
https://xconomy.com/boston/2020/06/30/goldfinch-raises-100m-for-kidney-drug-studies-now-perhaps-an-ipo-later/60%Monthly2020-06-30 16:29
https://xconomy.com/san-francisco/2020/06/30/code-for-cures-life-sciences-thrives-on-san-franciscos-software-heritage/60%Monthly2020-07-06 16:55
https://xconomy.com/san-diego/2020/06/29/roche-gets-fda-ok-for-injectable-version-of-breast-cancer-drug/60%Monthly2020-06-30 02:07
https://xconomy.com/san-diego/2020/06/29/fda-again-dings-herons-opioid-alternative-over-nonclinical-issues/60%Monthly2020-06-29 21:39
https://xconomy.com/new-york/2020/06/29/fda-says-no-to-intercept-pharmas-nash-drug-asks-for-more-data/60%Monthly2020-06-29 22:52
https://xconomy.com/national/2020/06/29/new-xconomy-special-report-biopharma-and-tech-innovators-summer-2020/60%Monthly2020-06-29 13:52
https://xconomy.com/national/2020/06/26/with-peanut-patch-in-fda-purgatory-dbv-plans-layoffs-to-stretch-cash/60%Monthly2020-06-26 22:12
https://xconomy.com/national/2020/06/26/eye-inflammation-dooms-abbvie-wet-amd-drug-to-an-fda-rejection/60%Monthly2020-06-26 17:43
https://xconomy.com/san-diego/2020/06/26/artiva-bio-raises-78m-to-broaden-access-to-cancer-cell-therapies/60%Monthly2020-06-26 18:09
https://xconomy.com/national/2020/06/26/bio-roundup-gileads-pionyr-grab-relay-to-ipo-unicorn-sana-more/60%Monthly2020-06-26 15:42
https://xconomy.com/philadelphia/2020/06/25/csl-behring-bolsters-hemophilia-lineup-with-deal-for-uniqures-gene-therapy/60%Monthly2020-06-25 20:21
https://xconomy.com/national/2020/06/25/fda-official-new-playbook-needed-for-cmc-reviews-of-gene-therapy-products/60%Monthly2020-06-25 14:10
https://xconomy.com/boston/2020/06/25/relay-lays-200m-ipo-plan-to-fund-tests-of-protein-motion-cancer-drugs/60%Monthly2020-07-09 21:02
https://xconomy.com/raleigh-durham/2020/06/24/eli-lilly-veteran-melemed-joins-chimerix-as-chief-medical-officer/60%Monthly2020-06-24 20:31
https://xconomy.com/san-diego/2020/06/24/la-jolla-pharma-steps-in-with-better-offer-wins-tetraphase-bidding-war/60%Monthly2020-06-24 14:53
https://xconomy.com/national/2020/06/24/asclepix-emerges-with-35m-and-an-eye-drug-challenger-to-eylea-lucentis/60%Monthly2020-06-24 13:37
https://xconomy.com/san-diego/2020/06/23/reneo-readies-for-global-test-of-drug-for-rare-mitochondrial-disease/60%Monthly2020-06-23 21:14
https://xconomy.com/san-francisco/2020/06/23/gilead-grabs-option-to-acquire-pionyr-its-clinic-bound-immunotherapies/60%Monthly2020-06-23 12:32
https://xconomy.com/san-francisco/2020/06/22/invitae-makes-a-precision-oncology-push-with-886m-deal-for-archerdx/60%Monthly2020-06-22 21:15
https://xconomy.com/boston/2020/06/22/sarepta-inks-codiak-deal-to-explore-combining-exosomes-muscle-meds/60%Monthly2020-06-22 18:58
https://xconomy.com/national/2020/06/22/new-panel-announced-for-next-weeks-ai-drug-discovery-conference-xcelerating-life-sciences-san-francisco/60%Monthly2020-06-22 16:32
https://xconomy.com/boston/2020/06/22/diversity-inclusion-events-have-halted-our-conversations-shouldnt/60%Monthly2020-06-23 14:04
https://xconomy.com/raleigh-durham/2020/06/19/shattuck-labs-nabs-118m-for-cancer-drugs-like-keytruda-but-better/60%Monthly2020-06-20 02:27
https://xconomy.com/philadelphia/2020/06/19/timing-is-an-essential-element-of-cell-gene-therapy-product-development/60%Monthly2020-07-06 16:56
https://xconomy.com/national/2020/06/19/bio-roundup-a-royal-ipo-akili-arrives-orca-bio-surfaces-more/60%Monthly2020-06-20 02:29
https://xconomy.com/boston/2020/06/19/in-microbiome-milestone-finch-therapeutics-c-diff-pill-bests-placebo/60%Monthly2020-06-19 02:07
https://xconomy.com/seattle/2020/06/18/alpine-immune-sciences-lands-abbvie-as-rd-partner-for-lupus-drug/60%Monthly2020-06-18 16:44
https://xconomy.com/san-diego/2020/06/18/engrail-therapeutics-launches-with-32m-to-develop-new-neuro-drugs/60%Monthly2020-06-18 12:02
https://xconomy.com/san-francisco/2020/06/17/orca-bio-surfaces-with-192m-and-recipes-for-custom-cell-therapies/60%Monthly2020-06-18 16:47
https://xconomy.com/san-diego/2020/06/17/frazier-launches-lassen-to-advance-antibodies-against-fibrosis-cancer/60%Monthly2020-06-17 20:40
https://xconomy.com/boston/2020/06/16/c4-therapeutics-adds-170m-to-test-protein-degraders-in-the-clinic/60%Monthly2020-06-17 02:36
https://xconomy.com/boston/2020/06/16/kaleido-bio-ceo-lawton-resigns-company-plans-search-for-successor/60%Monthly2020-06-17 13:12
https://xconomy.com/san-francisco/2020/06/16/kronos-bio-appoints-christopher-dinsmore-chief-scientific-officer/60%Monthly2020-06-16 22:32
https://xconomy.com/san-francisco/2020/06/16/astrazeneca-veteran-hasan-jafri-joins-aridis-as-chief-medical-officer/60%Monthly2020-06-16 22:23
https://xconomy.com/san-francisco/2020/06/16/gsk-expands-synthetic-lethality-scope-with-120m-ideaya-bio-alliance/60%Monthly2020-06-17 13:02
https://xconomy.com/san-francisco/2020/06/16/exec-search-underway-at-pacbio-after-ceo-cfo-announce-plans-to-retire/60%Monthly2020-06-16 20:51
https://xconomy.com/philadelphia/2020/06/16/pharma-partnering-perspectives-from-xcelerating-life-sciences-panel/60%Monthly2020-06-22 14:16
https://xconomy.com/national/2020/06/15/jazz-pharma-gets-quick-fda-ok-for-new-small-cell-lung-cancer-drug/60%Monthly2020-06-16 00:41
https://xconomy.com/boston/2020/06/15/akili-interactives-video-game-for-adhd-gets-the-fda-all-clear/60%Monthly2020-06-16 00:14
https://xconomy.com/national/2020/06/15/fda-reverses-authorization-for-use-of-antimalarials-to-treat-covid-19/60%Monthly2020-06-15 19:36
https://xconomy.com/national/2020/06/12/glaxosmithkline-keeps-oncology-2-0-growth-plans-on-track/60%Monthly2020-06-17 20:49
https://xconomy.com/national/2020/06/12/viela-bio-gets-fda-green-light-for-rare-autoimmune-disease-treatment/60%Monthly2020-06-12 23:02
https://xconomy.com/boston/2020/06/12/modernas-almarsson-jumps-to-lyndra-for-chief-technology-officer-post/60%Monthly2020-06-12 16:25
https://xconomy.com/national/2020/06/12/biotech-roundup-bio-on-racism-abbvie-antibodies-ipo-surge-more/60%Monthly2020-06-12 15:26
https://xconomy.com/boston/2020/06/11/novo-nordisk-strikes-a-725m-deal-for-astrazeneca-spinout-corvidia/60%Monthly2020-06-12 14:23
https://xconomy.com/texas/2020/06/11/reata-bags-350m-as-it-preps-rare-chronic-kidney-disease-drug-for-fda/60%Monthly2020-06-12 14:28
https://xconomy.com/boston/2020/06/11/moderna-finalizes-plan-dose-for-phase-3-test-of-mrna-covid-vaccine/60%Monthly2020-06-11 16:17
https://xconomy.com/boston/2020/06/11/verve-therapeutics-adds-63m-to-edit-heart-attack-risk-out-of-genes/60%Monthly2020-06-11 03:30
https://xconomy.com/national/2020/06/10/abbvie-commits-750m-to-genmab-bispecific-antibody-cancer-drug-deal/60%Monthly2020-06-11 17:20
https://xconomy.com/new-york/2020/06/10/mercks-keytruda-fails-pivotal-bladder-cancer-study-sinks-first-line-hopes/60%Monthly2020-06-11 03:36
https://xconomy.com/national/2020/06/10/fauci-foresees-more-than-1-winner-in-race-to-create-covid-19-vaccines-drugs/60%Monthly2020-06-10 12:09
https://xconomy.com/new-york/2020/06/09/melinta-expands-antibiotics-lineup-with-39m-tetraphase-acquisition/60%Monthly2020-06-24 14:55
https://xconomy.com/boston/2020/06/09/cerevasc-lands-44m-for-new-medical-device-to-drain-water-on-the-brain/60%Monthly2020-06-09 12:02
https://xconomy.com/boston/2020/06/09/iteos-therapeutics-taps-sareptas-gall-as-chief-financial-officer/60%Monthly2020-06-09 06:41
https://xconomy.com/san-francisco/2020/06/09/ardelyx-taps-correvios-justin-renz-as-its-chief-financial-officer/60%Monthly2020-06-09 06:21
https://xconomy.com/san-diego/2020/06/08/amplyx-appoints-miratis-chris-lemasters-as-chief-operating-officer/60%Monthly2020-06-09 01:49
https://xconomy.com/boston/2020/06/08/sarepta-eyes-key-test-for-gene-therapy-in-rare-muscular-dystrophy/60%Monthly2020-06-09 16:36
https://xconomy.com/boston/2020/06/08/akouos-aims-for-an-ipo-to-advance-hearing-loss-gene-therapy-to-clinic/60%Monthly2020-06-08 17:55
https://xconomy.com/new-york/2020/06/05/legend-biotechs-upsized-ipo-lands-424m-for-multiple-myeloma-drug/60%Monthly2020-06-10 21:04
https://xconomy.com/national/2020/06/05/bio-roundup-race-and-pharma-asco-recap-warp-speed-ahead-more/60%Monthly2020-06-08 19:17
https://xconomy.com/boston/2020/06/05/atlas-venture-raises-400m-fund-to-seed-another-set-of-biotechs/60%Monthly2020-06-05 15:32
https://xconomy.com/boston/2020/06/04/cullinan-oncology-reels-in-98m-to-advance-cancer-drug-pipeline/60%Monthly2020-06-04 20:55
https://xconomy.com/boston/2020/06/04/accent-astrazeneca-ink-cancer-drug-deal-to-block-rna-modifying-proteins/60%Monthly2020-06-04 20:51
https://xconomy.com/national/2020/06/04/early-bird-sale-ends-friday-june-5-for-xconomys-ai-drug-discovery-online-forum-and-networking-conference/60%Monthly2020-06-08 11:22
https://xconomy.com/boston/2020/06/03/nodthera-adds-55m-to-advance-drugs-to-better-regulate-inflammation/60%Monthly2020-06-04 13:07
https://xconomy.com/new-york/2020/06/03/cytovia-therapeutics-adds-olixs-wei-li-as-chief-scientific-officer/60%Monthly2020-06-03 20:07
https://xconomy.com/new-york/2020/06/03/aruvant-taps-sareptas-palaniappan-as-chief-technology-officer/60%Monthly2020-06-03 17:52
https://xconomy.com/philadelphia/2020/06/03/swanbio-therapeutics-appoints-zelenkofske-chief-medical-officer/60%Monthly2020-06-03 17:47
https://xconomy.com/san-francisco/2020/06/03/pliant-therapeutics-prices-ipo-lands-144m-to-test-fibrosis-drugs/60%Monthly2020-06-03 15:18
https://xconomy.com/raleigh-durham/2020/06/02/grail-plants-a-seed-in-rtp-pledges-100m-investment-in-new-site/60%Monthly2020-06-02 22:42
https://xconomy.com/seattle/2020/06/02/chinook-aduro-merger-plan-sets-up-new-kidney-disease-focused-biotech/60%Monthly2020-06-02 18:10
https://xconomy.com/san-diego/2020/06/01/samumed-taps-pfizers-michael-white-as-its-chief-scientific-officer/60%Monthly2020-06-01 20:15
https://xconomy.com/new-york/2020/06/01/regeneron-pays-intellia-100m-to-add-hemophilia-to-crispr-rd-pact/60%Monthly2020-06-01 17:36